Jubilant Ingrevia Q1 FY27: revenue up 25%, profit jumps 41%
JUBLINGREA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts less than Nifty Smallcap 250 and 1.2 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated revenue from operations rose 25.3 percent to Rs 1,300.27 crore from Rs 1,037.87 crore in Q1 FY26. Net profit jumped 40.9 percent to Rs 105.82 crore versus Rs 75.10 crore. EPS stood at Rs 6.70 versus Rs 4.75. Standalone net profit more than doubled to Rs 126.22 crore from Rs 59.01 crore. Operating margin expanded to 11.39 percent from 9.76 percent on a consolidated basis. All three segments, Speciality Chemicals, Nutrition and Health Solutions, and Chemical Intermediates, posted higher revenues and profits.
Strong broad-based growth across segments with margin expansion. Positive earnings beat likely to support stock sentiment in the near term.